6.1 Acute Coronary Syndrome (ACS) and 12-Lead Interpretation

Acute Coronary Syndrome (ACS) and 12-Lead Interpretation

Acute Coronary Syndrome (ACS) constitutes a spectrum of clinical presentations ranging from unstable angina (UA) and non-ST-segment elevation myocardial infarction (NSTEMI) to ST-segment elevation myocardial infarction (STEMI). At the core of ACS pathophysiology is the rupture or erosion of an unstable, lipid-rich atherosclerotic plaque. This exposure of the subendothelial matrix triggers platelet adhesion, activation, and aggregation, culminating in local thrombus formation. If the thrombus is transient or partially occlusive, it results in unstable angina or NSTEMI, characterized by subendocardial ischemia. Conversely, a persistent, fully occluding thrombus leads to transmural myocardial infarction, recognized on a 12-lead electrocardiogram (ECG) as STEMI.

In critical care transport, rapid and precise 12-lead ECG interpretation is paramount to direct patient destinations, facilitate pre-arrival activation of the cardiac catheterization lab, and optimize pharmacotherapy. A standard 12-lead ECG is obtained using 10 electrodes: 4 limb leads and 6 precordial leads. These electrodes provide 12 distinct electrical viewpoints of the myocardium. Proper lead placement is essential, as deviation by even a single intercostal space can lead to diagnostic errors. The precordial leads are anatomically positioned as follows:

• V1: Fourth intercostal space (ICS) at the right sternal border.
• V2: Fourth ICS at the left sternal border.
• V3: Midway between leads V2 and V4.
• V4: Fifth ICS at the left midclavicular line.
• V5: Horizontal to lead V4 at the left anterior axillary line.
• V6: Horizontal to lead V4 at the left midaxillary line.

Electrocardiographic Localization and Culprit Vessels

To localize myocardial ischemia, injury, or infarction, clinicians examine contiguous leads, which are leads that look at the same anatomical region of the heart. The primary anatomical lead groups and their corresponding coronary arteries are outlined below:

Inferior Wall (Leads II, III, aVF)

• Culprit Vessel: The Right Coronary Artery (RCA) is the culprit vessel in approximately 80-85% of inferior infarctions. In the remaining cases, a dominant Left Circumflex (LCx) artery is responsible.
• Clinical Considerations: The RCA supplies the sinoatrial (SA) node in about 60% of individuals and the atrioventricular (AV) node in 90% (in right-dominant coronary anatomy). Consequently, inferior STEMIs are frequently complicated by bradyarrhythmias, sinus arrest, and high-grade AV blocks. Furthermore, up to 40% of inferior infarctions involve the right ventricle.

Right Ventricular Infarction (RVI)

Right ventricular infarction (RVI) is a critical diagnostic subset of inferior STEMIs. The right ventricular myocardium is thin-walled and highly dependent on preload (venous return) to maintain cardiac output. A standard 12-lead ECG does not adequately visualize the right ventricle. Therefore, in any patient presenting with an inferior STEMI, a right-sided ECG is mandatory.

• Right-Sided Lead Placement: The precordial leads are placed in a mirrored fashion on the right side of the chest (V1R to V6R). Lead V4R, placed in the fifth intercostal space at the right midclavicular line, is the most clinically sensitive lead for right ventricular involvement.
• Diagnostic Criteria: An ST-segment elevation of >= 0.5 mm (or >= 1.0 mm in males under 30) in lead V4R is diagnostic of right ventricular infarction.
• Hemodynamic Management: Patients with RVI are extremely preload-sensitive. Standard ACS therapies that reduce preload-such as nitroglycerin, morphine, and loop diuretics-can cause profound, refractory hypotension and cardiogenic shock. These agents are strictly contraindicated in RVI. If hypotension occurs, it must be treated aggressively with intravenous fluid boluses (e.g., 250-500 mL of normal saline or lactated Ringer's, titrated up to several liters) to maintain right-sided filling pressures and force blood through the pulmonary circulation.

Anterior Wall (Leads V3, V4) and Septal Wall (Leads V1, V2)

• Culprit Vessel: The Left Anterior Descending (LAD) coronary artery, often referred to as the 'widowmaker'.
• Clinical Considerations: The LAD supplies the large muscular anterior wall of the left ventricle and the interventricular septum, which houses the bundle branches. Anterior STEMIs are associated with a high incidence of cardiogenic shock, left-sided congestive heart failure, and new-onset conduction defects (such as Left Bundle Branch Block [LBBB] or Right Bundle Branch Block [RBBB] with left anterior hemiblock).

Lateral Wall (Leads I, aVL, V5, V6)

• Culprit Vessel: The Left Circumflex (LCx) artery, or diagonal branches of the LAD.
• Clinical Considerations: Leads I and aVL represent the high lateral wall, while V5 and V6 view the low lateral wall. Isolated lateral infarctions can be subtle, presenting with reciprocal ST-segment depression in the inferior leads (II, III, aVF) before obvious ST-elevation develops in I and aVL.

Posterior Wall (Leads V7, V8, V9)

• Culprit Vessel: Left Circumflex (LCx) or Right Coronary Artery (RCA).
• Electrocardiographic Signs: Because no standard ECG leads directly face the posterior wall, posterior infarctions must be suspected when reciprocal changes are seen in the anterior leads V1, V2, and V3. These signs include horizontal ST-segment depression, tall and wide R waves (>= 0.04 seconds duration), and upright, symmetrical T waves.
• Posterior Lead Placement: To confirm a posterior STEMI, a posterior ECG is performed. Leads V7 (posterior axillary line), V8 (mid-scapular line), and V9 (left paraspinal line) are placed at the same horizontal level as V6. An ST-segment elevation of >= 0.5 mm in leads V7-V9 is diagnostic of an acute posterior myocardial infarction.

STEMI Equivalents and Diagnostic Challenges: Sgarbossa Criteria

Diagnosing an acute myocardial infarction in the presence of a pre-existing Left Bundle Branch Block (LBBB) or a ventricular-paced rhythm is a classic clinical challenge. Both conditions alter ventricular depolarization, causing secondary ST-segment and T-wave changes that typically run opposite (discordant) to the main QRS vector. The Sgarbossa Criteria provide a validated, point-based scoring system to identify acute STEMI in these patients:

1. Concordant ST-segment elevation >= 1 mm in any lead with a positive (upright) QRS complex (5 points). This is the most specific predictor of MI.
2. Concordant ST-segment depression >= 1 mm in lead V1, V2, or V3 (3 points).
3. Discordant ST-segment elevation >= 5 mm in any lead with a negative (downward) QRS complex (2 points).

Note on the Modified Sgarbossa Criteria: The third criterion has been updated in modern clinical guidelines to improve sensitivity. The modified rule replaces the absolute 5 mm limit with a proportional limit: an ST-elevation-to-S-wave amplitude ratio of <= -0.25 (meaning the ST elevation is at least 25% of the preceding S-wave depth).

A score of >= 3 points on the original Sgarbossa scale has a specificity of 98% for acute MI, indicating the need for immediate emergent reperfusion therapy.

Transport Management and Reperfusion Timelines

The primary goal of transport management in STEMI is minimizing myocardial injury by maximizing oxygen delivery and reducing the time to coronary artery reperfusion.

• Oxygen Therapy: Supplemental oxygen should be titrated to maintain an oxygen saturation (SpO2) between 90% and 94% (AHA/ACC guidelines). Routine administration of high-flow oxygen to non-hypoxic patients is avoided, as hyperoxia causes coronary artery vasoconstriction, increases systemic vascular resistance, and may increase infarct size.
• Antiplatelet Therapy: Administer non-enteric coated Aspirin (162-325 mg) chewed immediately to inhibit platelet aggregation by blocking thromboxane A2 synthesis.
• Nitroglycerin: Administer 0.4 mg sublingually every 5 minutes (up to 3 doses) for active ischemic chest pain, provided the systolic blood pressure is > 90 mmHg. Ensure that there is no right-sided involvement (V4R positive) or recent phosphodiesterase-5 inhibitor use.
• Anticoagulation: Administer Unfractionated Heparin (UFH) as an intravenous bolus (60 units/kg, maximum 4,000 units) followed by an infusion (12 units/kg/h, maximum 1,000 units/h) to prevent thrombus propagation.
• Reperfusion Timelines: For patients presenting with STEMI, primary Percutaneous Coronary Intervention (PCI) is the preferred reperfusion strategy. The target door-to-balloon time is <= 90 minutes if presenting to a PCI-capable facility. If the patient presents to a non-PCI-capable facility, the target door-in-door-out (DIDO) time is <= 30 minutes. If the anticipated transport time from first medical contact to balloon inflation at a PCI-capable facility exceeds 120 minutes, fibrinolytic therapy (e.g., tenecteplase, alteplase) must be initiated within 30 minutes of arrival, provided the patient has no absolute contraindications.